P2.01-01 The Impact of Anlotinib on Brain Metastases of NSCLC: Post-Hoc Analysis of a Phase III Randomized Control Trial (ALTER0303)

    X. Han
    X. Han
    Xue-Ning Yang
    Xue-Ning Yang
    B. Han
    B. Han

    Journal of Thoracic Oncology, 2018.

    Cited by: 0|Bibtex|Views1|

    Code:

    Data:

    Your rating :
    0

     

    Tags
    Comments